Drugs

Title

Date Published

Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.

April 1, 2006

Successful Treatment of Life-threatening Bleeding after Cesarean Section with Recombinant Activated Factor VII.

April 1, 2006

Traumatic hemoptysis treated with recombinant human factor VIIa.

April 1, 2006

Successful management of bleeding with recombinant factor VIIa (NovoSeven(R)) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins.

March 2, 2006

Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review.

March 1, 2006

Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.

March 1, 2006

Recombinant Activated Factor VII: Treating Postoperative Hemorrhage in Cardiac Surgery.

March 1, 2006

Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans.

March 1, 2006

Aprotinin in cardiac surgery.

March 1, 2006

Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin.

March 1, 2006

A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.

March 1, 2006

Aprotinin versus tranexamic acid: the controversy continues.

March 1, 2006

Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: A prospective randomised controlled trial of 29 patients.

February 14, 2006

The use of recombinant activated factor VII for refractory bleeding post complex cardiothoracic surgery.

February 1, 2006

Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial.

February 1, 2006

Evaluation of FloSeal as a Potential Intracavitary Hemostatic Agent.

February 1, 2006

Damage Control Management of Experimental Grade 5 Renal Injuries: Further Evaluation of FloSeal Gelatin Matrix.

February 1, 2006

Perioperative management of oral anticoagulation: when and how to bridge.

February 1, 2006

The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model.

February 1, 2006

Recombinant Factor VIIa: A Review on Its Clinical Use.

February 1, 2006